Literature DB >> 23253317

Frequency of the off-label use of antibiotics in clinical practice: a systematic review.

Giannoula S Tansarli1, Petros I Rafailidis, Anastasios Kapaskelis, Matthew E Falagas.   

Abstract

Antibiotics constitute a major class among drugs commonly prescribed either empirically or for microbiologically documented infections in clinical practice. In addition, due to medical necessity physicians are forced, at times, to prescribe medications for off-label indications. The authors sought to record the frequency of the off-label use of antibiotics among both adult and pediatric patients. PubMed and Scopus databases were searched to identify relevant studies. A total of 25 studies met the inclusion criteria (725,124,505 prescriptions); 16 were prospective and nine retrospective. Fifteen studies reported on the pediatric population, seven on adults who had received a specific antibiotic, two on adult critical-care patients, and one on the general outpatient population. In the pediatric population, the percentage of off-label prescriptions varied from 1 to 94%. Off-label prescriptions varied from 19 to 43% in adult critical-care patients. Last, one study reporting on general outpatient care showed that 23% of prescriptions were off-label. Antibiotics are frequently prescribed as off-label among patient populations. The wide variation observed in the off-label use of antibiotics among pediatric patients might be attributed to the heterogeneity among the study populations regarding the age of children. Although this unapproved manner of prescribing cannot always be avoided, clinicians should only use unapproved drugs in cases when there are no effective alternatives are available and based on scientific evidence regarding safety and effectiveness.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23253317     DOI: 10.1586/eri.12.137

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  5 in total

Review 1.  Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.

Authors:  Matthew E Falagas; Panagiota Lourida; Panagiotis Poulikakos; Petros I Rafailidis; Giannoula S Tansarli
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

2.  An outpatient antibacterial stewardship intervention during the journey to JCI accreditation.

Authors:  Ping Song; Wei Li; Quan Zhou
Journal:  BMC Pharmacol Toxicol       Date:  2014-02-26       Impact factor: 2.483

3.  The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever: A Randomized Controlled Trial.

Authors:  Robert van Haselen; Manuela Thinesse-Mallwitz; Vitaliy Maidannyk; Stephen L Buskin; Stephan Weber; Thomas Keller; Julia Burkart; Petra Klement
Journal:  Glob Pediatr Health       Date:  2016-07-04

4.  Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers.

Authors:  Hélène Thirot; Caroline Briquet; Frédéric Frippiat; Frédérique Jacobs; Xavier Holemans; Séverine Henrard; Paul M Tulkens; Anne Spinewine; Françoise Van Bambeke
Journal:  Antibiotics (Basel)       Date:  2021-05-04

5.  Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project.

Authors:  Zaira R Palacios-Baena; Lucia Valiente de Santis; Natalia Maldonado; Clara M Rosso-Fernández; Irene Borreguero; Carmen Herrero-Rodríguez; Salvador López-Cárdenas; Franciso J Martínez-Marcos; Andrés Martín-Aspas; Patricia Jiménez-Aguilar; Juan J Castón; Francisco Anguita-Santos; Guillermo Ojeda-Burgos; M Pilar Aznarte-Padial; Julia Praena-Segovia; Juan E Corzo-Delgado; M Ángeles Esteban-Moreno; Jesús Rodríguez-Baño; Pilar Retamar
Journal:  BMJ Open       Date:  2020-07-31       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.